跳至主要内容
临床试验/NCT00602186
NCT00602186Unknown1 期

Effect of Tamsulosin vs Prazosin in Treatment of Female Voiding Dysfunction

Tabriz University0 个研究点目标入组 80 人开始时间: 2005年7月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
发起方
入组人数
80
主要终点
patient symptoms improvement(Standard questionare)

研究概览

简要总结

The purpose of this study is to determine whether Tamsolusin or Prazosin are effective in the treatment of female voiding dysfunction(BOO)

详细描述

Voiding dysfunction is not uncommon in Tabriz.About 20% of patients in female urology clinic of Tabriz university of medical sciences sufered from some degrees of voiding dysfunction (due to bladder imparement or bladder outlet obstruction).There is limited information about medical treatment of those patients. On the other hand alpha adrenergic blockers are the first choice medication in BENIGN PROSTATIC HYPERPLASIA. There is some new facts about destribution of alpha adrenergic blockers in female pelvic floor.The purpose of this study is to comparision whether Tamsolusin 0.4/daily or Prazosin 1 mg/daily are effective in the treatment of female voiding dysfunction(BOO)

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
20 Years 至 70 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Healthy females with voiding difficulty with MFR<12 and post void residual urine>50cc

排除标准

  • History of pelvic floor surgury during last 3 month
  • Any contraindication for Tamsolusin or prazosin

研究组 & 干预措施

1

Experimental

taking Tamsulosin

干预措施: tamsolusin (Drug)

2

Active Comparator

taking prasosin

干预措施: prazosin (Drug)

结局指标

主要结局

patient symptoms improvement(Standard questionare)

时间窗: every month untile 3 months

次要结局

  • Urodynamics parameters improvement(three months later)

研究者

发起方
Tabriz University
申办方类型
Other

相似试验